Stay updated on Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the efficacy and safety evaluation of oral difelikefalin as adjunct therapy to a topical corticosteroid for moderate-to-severe pruritus in adult subjects with atopic dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:40:36.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The webpage has been updated to provide detailed eligibility criteria for study participation, including specific health conditions and prior treatments required for inclusion. Previously, no information was provided about the participation criteria.
    Difference
    10%
    Check dated 2024-05-22T21:35:20.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:43:00.000Z thumbnail image

Stay in the know with updates to Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Oral Difelikefalin Adjunct in Atopic Dermatitis Clinical Trial page.